704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer
oleh: Qingfeng Zhu, Robert Anders, Damian Trujillo, Dirk G Brockstedt, Michael Chisamore, Juraj Adamik, Paul D Kassner, William Ho, Rakesh Kumar Goyal, Adam Grant, Shoji Ikeda, Marvin Au, Denise Nagata, Eugene Lurie, Mohsen Sabouri Ghomi
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.